STELTO — 1393862
Application number
1393862
Type(s)
Word
Category
Trademark
CIPO Status
ABANDONED SECTION 40(3)
TM5 status
DEAD/APPLICATION/
Withdrawn/Abandoned
The owner of the trademark application withdrew (e.g. abandoned) the application and the application is no longer active.
Filed
2008-05-01
Applicant
Pfizer Inc.
235 East 42nd Street
New York, New York 10017
UNITED STATES OF AMERICA
Agent
TORYS LLP
SUITE 3000
79 WELLINGTON ST. W.
BOX 270, TD CENTRE
TORONTO
ONTARIO M5K1N2
Documents
Index headings
- STELTO
Goods (Nice class & Statement)
- (1) Pharmaceutical preparations for the prevention and/or treatment of: cardiovascular disease; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, and smoking habits or addictions; neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy, multiple sclerosis; genitourinary diseases and disorders, namely urological diseases, urological disorders, urinary incontinence, infertility, sexually transmitted diseases, inflammatory pelvic diseases, premature ejaculation; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; allergies; diabetes; hypertension; erectile dysfunction; sexual dysfunction; metabolic diseases and disorders; hemolytic diseases and disorders; cancer; migraines; pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain, post-herpetic neuralgia; chronic pain; fibromyalgia; obesity; inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; the respiratory system; infectious diseases, namely respiratory infections, eye infections; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, HIV, Acquired Immune Deficiency Syndrome (AIDS); viral diseases and disorders, namely herpes, hepatitis, HIV, Acquired Immune Deficiency Syndrome (AIDS); stroke; psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, bipolar disorder, cognitive disorders, schizophrenia, depression; substance abuse disorders, namely alcoholism and drug addiction; carpal tunnel syndrome; varicose veins; dental and oral diseases; osteoporosis; arthritis; multiple sclerosis; yeast infections; prostate disorders; pulmonary disorders; sleep disorders, namely, insomnia and restless leg syndrome; premature ejaculation; macular degeneration; thrombosis; and thromboembolism; (2) pharmaceutical preparations for: use in oncology; dermatology, namely dermatitis, skin pigmentation diseases; ophthalmology; ocular disorders; gastroenterology; and gynecology; (3) pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; smoking cessation preparations; tissue and skin repair preparations; acne medication; allergy medication; antacids; anthelmintics; antiarrhythmics; antibiotics; anticoagulants; anticonvulsants; antidepressants; antiemetics; antiflatulants; antihistamines; antihypertensives; anti-infectives; anti-inflammatories; antiparasitics; antibacterials; antifungals; antivirals; burn relief medication; calcium channel blockers; central nervous system depressants; central nervous system stimulants; cough treatment medication; diarrhea medication; gastrointestinal medication; glaucoma agents; hydrocortisone; hypnotic agents; sedatives; and ophthalmic preparations.
Classification data
Disclaimer
The classification data is provided for information and searching purposes only. CIPO does not warrant the accuracy of the classes assigned to the trademark. This data has no legal value of any kind.
- 5 - Pharmaceuticals and herbicides
Claims
- Proposed Use in CANADA
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2008-05-01 | ||
| Created | 2008-05-02 | ||
| Formalized | 2008-05-05 | ||
| Search Recorded | 2009-01-29 | ||
| Examiner's First Report | 2009-01-29 | 2009-05-29 | |
| Approval Notice Sent | 2009-06-22 | 2009-07-20 | |
| Approved | 2009-08-13 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2009-08-19 | Vol.56 Issue 2860 | |
| Allowed | 2009-12-04 | ||
| Allowance Notice Sent | 2009-12-04 | 2011-05-01 | |
| Extension of Time | 2011-05-09 | 2011-11-01 | Request Letter Date: 2011/05/02 |
| Extension of Time | 2011-11-08 | 2012-05-01 | Request Letter Date: 2011/11/01 |
| Rep for Service Changed | 2012-04-30 | From: 8390 To: 6258 / Voir Preuve au dossier/See evidence on File No. 1309785 | |
| Agent Changed | 2012-04-30 | From: 8390 To: 6258 / Voir Preuve au dossier/See evidence on File No. 1309785 | |
| Extension of Time | 2012-05-10 | 2012-11-01 | Request Letter Date: 2012/05/01 |
| Extension of Time | 2012-11-01 | 2013-05-01 | Request Letter Date: 2012/10/25 |
| Extension of Time | 2013-05-01 | 2013-11-01 | Request Letter Date: 2013/04/25 |
| Extension of Time | 2013-11-04 | 2014-05-01 | Request Letter Date: 2013/10/24 |
| Correspondence Created | 2014-05-12 | 2014-11-01 | |
| Abandoned - Subsection 40(3) | 2014-11-19 |